Editorial Team
🇪🇺 EMANamed contributors covering Europe & United Kingdom pharmaceutical intelligence — 9 editors with published articles.
Quick answer
NovaPharmaNews Europe & United Kingdom edition lists 9 named editorial contributors with 595 published articles — EMA drug approvals, clinical trials, manufacturing, and market intelligence attributed to accountable experts.
Contributors
- Dr. Elena Rossi PhD Pharmaceutical Sciences EMA Regulatory Affairs Editor 376 articles Dr. Rossi specializes in European Medicines Agency approvals and CHMP opinions.
- Prof. Marcus Webb MPharm, PhD UK Pharma Policy Analyst 58 articles Prof. Webb covers MHRA and EMA regulatory developments across the European market.
- Dr. Amina Farouk MD, MSc Pharmacovigilance Global Safety and Pharmacovigilance Analyst 29 articles Dr. Amina Farouk analyzes safety updates, risk mitigation plans, and post-market surveillance trends. She has 15 years of pharmacovigilance experience supporting multinational product teams across oncology, immunology, and cardiovascular portfolios.
- Dr. Hannah O'Connor PhD, Translational Medicine Advanced Therapies Columnist 27 articles Dr. Hannah O'Connor writes on advanced therapy medicinal products, translational milestones, and EU regulatory expectations. Across 13 years in translational medicine, she has advised teams on target validation and evidence packages for high-impact programs.
- Matteo Ricci MSc, Health Economics Health Policy and Access Writer 27 articles Matteo Ricci reports on HTA evaluations, pricing negotiations, and reimbursement updates across major EU markets. His 10 years in health economics coverage focus on the practical impact of payer evidence standards for launch sequencing.
- Sofia Alvarez MBA Biopharma Partnerships Reporter 25 articles Sofia Alvarez covers European partnership activity, co-development structures, and licensing economics. Over 7 years, she has specialized in explaining how alliance terms affect risk-sharing, commercialization rights, and long-term portfolio value.
- Oliver Grant BSc, Biostatistics Junior Pharma Data Reporter 21 articles Oliver Grant focuses on conference datasets, endpoint interpretation, and comparative clinical performance in EU-focused programs. In 3 years of reporting, he has developed strong skills in presenting complex data in clear, decision-oriented formats.
- Charlotte Meyer MSc, Regulatory Science EMA Regulatory Affairs Correspondent 17 articles Charlotte Meyer tracks EMA opinions, CHMP decisions, and post-authorization commitments across Europe. With 11 years in regulatory intelligence, she helps teams understand how policy harmonization and national reimbursement dynamics influence launch strategy.
- Dr. Lukas Schneider MD, PhD European Clinical Development Editor 15 articles Dr. Lukas Schneider brings 18 years of oncology development experience spanning trial operations and medical affairs. His coverage emphasizes EU study design trends, translational data quality, and cross-border development execution.
Frequently asked questions
Who are the NovaPharmaNews editorial contributors?
This directory lists regional editors and analysts with published intelligence on NovaPharmaNews. Each profile shows credentials, coverage focus, and a full article archive for transparency and E-E-A-T.
How is regional coverage organised?
Authors are grouped by regional edition — Americas (FDA), Europe (EMA), or Asia-Pacific (PMDA/NMPA). Open a profile to see that contributor’s published news and analysis.
Where can I read the editorial standards?
See our Editorial Policy and Methodology pages for sourcing rules, correction process, and how human experts validate AI-assisted analysis.